US Patent Issued to Institute for Systems Biology, The United States of America as Represented by The Secretary of the Army on Jan. 28 for "SARS-CoV-2 epitope-targeted peptide immunostimulants" (Washington, Maryland Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,209,142, issued on Jan. 28, was assigned to Institute for Systems Biology (Seattle) and The United States of America as Represented by The Secretary of the Army (Washington).

"SARS-CoV-2 epitope-targeted peptide immunostimulants" was invented by James R. Heath (Seattle), Matthew Idso (Seattle), Alexander J. Winton (Adelphi, Md.), Matthew B. Coppock (Adelphi, Md.) and Sanchao Liu (Adelphi, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compounds, compositions, and methods relating to epitope-targeted immunostimulants (EPIs), which comprise a synthetic peptide ligand an antibody-recruiting moiety. The peptide ligand binds an epitope on a...